Predictive Oncology Inc (POAI)
0.7401
-0.07
(-8.63%)
USD |
NASDAQ |
Nov 14, 16:00
0.7479
+0.01
(+1.05%)
After-Hours: 20:00
Predictive Oncology Gross Profit (Annual): 1.145M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.145M |
| December 31, 2022 | 1.000M |
| December 31, 2021 | 0.9337M |
| December 31, 2020 | 0.8051M |
| December 31, 2019 | 0.8798M |
| December 31, 2018 | 0.9959M |
| December 31, 2017 | 0.5068M |
| December 31, 2016 | 0.2749M |
| Date | Value |
|---|---|
| December 31, 2015 | 0.3504M |
| December 31, 2014 | 0.5662M |
| December 31, 2013 | 0.2784M |
| December 31, 2012 | 0.0602M |
| December 31, 2011 | 0.0406M |
| December 31, 2010 | 0.0001M |
| December 31, 2009 | 0.0087M |
| December 31, 2008 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
0.8051M
Minimum
2020
1.145M
Maximum
2023
0.9528M
Average
0.9337M
Median
2021
Gross Profit (Annual) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 9.108M |
| InfuSystems Holdings Inc | 63.11M |
| Xtant Medical Holdings Inc | 55.47M |
| Catheter Precision Inc | 0.412M |